Osteosarcoma is the most common primary bone cancer affecting children and adolescents worldwide. Despite an incidence of three cases per million annually, it accounts for an inordinate amount of morbidity and mortality. While the use of chemotherapy (cisplatin, doxorubicin, and methotrexate) in the last century initially resulted in marginal improvement in survival over surgery alone, survival has not improved further in the past four decades. Patients with metastatic osteosarcoma have an especially poor prognosis, with only 30% overall survival. Hence, there is a substantial need for new therapies. The inability to control the metastatic progression of this localized cancer stems from a lack of complete knowledge of the biology of osteosarcoma. Consequently, there has been an aggressive undertaking of scientific investigation of various signaling pathways that could be instrumental in understanding the pathogenesis of osteosarcoma. Here, we review these cancer signaling pathways, including Notch, Wnt, Hedgehog, phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT, and JAK/STAT, and their specific role in osteosarcoma. In addition, we highlight numerous natural compounds that have been documented to target these pathways effectively, including curcumin, diallyl trisulfide, resveratrol, apigenin, cyclopamine, and sulforaphane. We elucidate through references that these natural compounds can induce cancer signaling pathway manipulation and possibly facilitate new treatment modalities for osteosarcoma.
Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, Forni C, Briccoli A. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008;98:415–20. CrossRefPubMed
Tsuru A, Setoguchi T, Matsunoshita Y, Nagao-Kitamoto H, Nagano S, Yokouchi M, Maeda S, Ishidou Y, Yamamoto T, Komiya S. Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression. Br J Cancer. 2015;112:1232–40. CrossRefPubMedPubMedCentral
Wang DZ, Gao JF, Jing SF, Wei H, Huang XY, Li CD. Antitumor effect of docetaxel in osteosarcoma by the inhibition of Wnt signal channel. Drug Res (Stuttg). 2014;65(11):597–601.
Zhao S, Kurenbekova L, Gao Y, Roos A, Creighton CJ, Rao P, Hicks J, Man TK, Lau C, Brown AM, et al. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene. 2015;34(39):5069–79.
Kumar RM, Fuchs B. Hedgehog signaling inhibitors as anti-cancer agents in osteosarcoma. Cancers (Basel). 2015;7:784–94. CrossRef
Warzecha J, Dinges D, Kaszap B, Henrich D, Marzi I, Seebach C. Effect of the Hedgehog-inhibitor cyclopamine on mice with osteosarcoma pulmonary metastases. Int J Mol Med. 2012;29:423–7. PubMed
Yu Y, Luk F, Yang JL, Walsh WR. Ras/Raf/MEK/ERK pathway is associated with lung metastasis of osteosarcoma in an orthotopic mouse model. Anticancer Res. 2011;31:1147–52. PubMed
Choi SD. Ezrin is an essential marker for metastasis of gynecologic cancer. J Korean Soc Menopause. 2012;18:81–93. CrossRef
Zhang J, Zuo J, Lei M, Wu S, Zang X, Zhang C. Ezrin promotes invasion and migration of the MG63 osteosarcoma cell. Chin Med J (Engl). 2014;127:1954–9.
Celik H, Hong SH, Colon-Lopez DD, Han J, Saygideger Kont Y, Minas TZ, Swift M, Paige M, Glasgow E, Toretsky JA, et al. Identification of novel ezrin inhibitors targeting metastatic osteosarcoma by screening open access malaria box. Mol Cancer Ther. 2015;14(11);2497–507.
Cokic VP, Mitrovic-Ajtic O, Beleslin-Cokic BB, Markovic D, Buac M, Diklic M, Kraguljac-Kurtovic N, Damjanovic S, Milenkovic P, Gotic M, Raj PK. Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms. Mediators Inflamm. 2015;2015:453020.
Ferrucci V, Boffa I, De Masi G, Zollo M. Natural compounds for pediatric cancer treatment. Naunyn Schmiedebergs Arch Pharmacol. 2016:389(2):131-49.
Tutel’ian VA, Lashneva NV. Biologically active substances of plant origin. Flavonols and flavones: prevalence, dietary sourses and consumption. Vopr Pitan. 2013;82:4–22.
Liu X, Li L, Lv L, Chen D, Shen L, Xie Z. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/beta-catenin signaling pathway. Oncol Rep. 2015;34:1035–41. PubMed
Zhu DM, Xue WL, Tao W, Li JC. Effects of cyclopamine on the biological characteristics of human breast cancer MCF-7 cell line and its mechanism. Eur J Gynaecol Oncol. 2015;36:469–72. PubMed
Lu ZY, Lu LD, Liang-Hong MA. Effects of cyclopamine on the proliferation and apoptosis of LNCaP cells and expression of the PCA3 gene in human prostate cancer. Zhonghua Nan Ke Xue. 2014;20:213–7. PubMed
Sawai Y, Murata H, Horii M, Koto K, Matsui T, Horie N, Tsuji Y, Ashihara E, Maekawa T, Kubo T, Fushiki S. Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cells. Oncol Rep. 2013;29:941–5. PubMed
FerreiradeOliveira JM, Remedios C, Oliveira H, Pinto P, Pinho F, Pinho S, Costa M, Santos C. Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis. Nutr Cancer. 2014;66:325–34. CrossRef
Margolis B, Skolnik EY. Activation of Ras by receptor tyrosine kinases. J Am Soc Nephrol. 1994;5:1288–99. PubMed
- Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II